Coloplast As Stock Operating Margin
| CBHD Stock | 78.26 0.26 0.33% |
Fundamental analysis of Coloplast A/S allows traders to better anticipate movements in Coloplast A/S's stock price by examining its financial health and performance throughout various phases of its business cycle.
Coloplast |
Coloplast AS Company Operating Margin Analysis
Coloplast A/S's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Coloplast AS has an Operating Margin of 0.0%. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Healthcare Equipment & Supplies (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Coloplast Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Coloplast A/S's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Coloplast A/S could also be used in its relative valuation, which is a method of valuing Coloplast A/S by comparing valuation metrics of similar companies.Coloplast is currently under evaluation in operating margin category among its peers.
Coloplast Fundamentals
| Return On Equity | 80.33 | |||
| Current Valuation | 27.36 B | |||
| Price To Book | 21.45 X | |||
| Price To Sales | 7.90 X | |||
| Revenue | 22.58 B | |||
| EBITDA | 7.23 B | |||
| Net Income | 6.44 B | |||
| Total Debt | 16.36 B | |||
| Cash Flow From Operations | 5.1 B | |||
| Price To Earnings To Growth | 3.24 X | |||
| Market Capitalization | 22.73 B | |||
| Total Asset | 34.96 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.12 % | |||
| Net Asset | 34.96 B | |||
| Last Dividend Paid | 1.2 |
About Coloplast A/S Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Coloplast AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coloplast A/S using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coloplast AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Coloplast Stock
Coloplast A/S financial ratios help investors to determine whether Coloplast Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast A/S security.